Chemists discover structure of cancer drug candidate
Monday, May 19, 2014 - 15:30
in Health & Medicine
Chemists at The Scripps Research Institute (TSRI) have determined the correct structure of a highly promising anticancer compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials in cancer patients.